Craving in Alcohol-Dependent Patients After Detoxification Is Related to Glutamatergic Dysfunction in the Nucleus Accumbens and the Anterior Cingulate Cortex

The upregulation of glutamatergic excitatory neurotransmission is thought to be partly responsible for the acute withdrawal symptoms and craving experienced by alcohol-dependent patients. Most physiological evidence supporting this hypothesis is based on data from animal studies. In addition, clinic...

Full description

Saved in:
Bibliographic Details
Published inNeuropsychopharmacology (New York, N.Y.) Vol. 38; no. 8; pp. 1401 - 1408
Main Authors Bauer, Jochen, Pedersen, Anya, Scherbaum, Norbert, Bening, Johanna, Patschke, Johanna, Kugel, Harald, Heindel, Walter, Arolt, Volker, Ohrmann, Patricia
Format Journal Article
LanguageEnglish
Published Basingstoke Nature Publishing Group 01.07.2013
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The upregulation of glutamatergic excitatory neurotransmission is thought to be partly responsible for the acute withdrawal symptoms and craving experienced by alcohol-dependent patients. Most physiological evidence supporting this hypothesis is based on data from animal studies. In addition, clinical data show that GABAergic and anti-glutamatergic drugs ameliorate withdrawal symptoms, offering indirect evidence indicative of glutamatergic hyperexcitability in alcohol-dependent subjects. We used proton magnetic resonance spectroscopy to quantify the glutamate (Glu) levels in healthy control subjects and in alcohol-dependent patients immediately after detoxification. The volumes of interest were located in the nucleus accumbens (NAcc) and the anterior cingulate cortex (ACC), which are two brain areas that have important functions in reward circuitry. In addition to Glu, we quantified the levels of combined Glu and glutamine (Gln), N-acetylaspartate, choline-containing compounds, and creatine. The Glu levels in the NAcc were significantly higher in patients than in controls. Craving, which was measured using the Obsessive Compulsive Drinking Scale, correlated positively with levels of combined Glu and Gln in the NAcc and in the ACC. The levels of all other metabolites were not significantly different between patients and controls. The increased Glu levels in the NAcc in alcohol-dependent patients shortly after detoxification confirm the animal data and suggest that striatal glutamatergic dysfunction is related to ethanol withdrawal. The positive correlation between craving and glutamatergic metabolism in both key reward circuitry areas support the hypothesis that the glutamatergic system has an important role in the later course of alcohol dependence with respect to abstinence and relapse.
AbstractList The upregulation of glutamatergic excitatory neurotransmission is thought to be partly responsible for the acute withdrawal symptoms and craving experienced by alcohol-dependent patients. Most physiological evidence supporting this hypothesis is based on data from animal studies. In addition, clinical data show that GABAergic and anti-glutamatergic drugs ameliorate withdrawal symptoms, offering indirect evidence indicative of glutamatergic hyperexcitability in alcohol-dependent subjects. We used proton magnetic resonance spectroscopy to quantify the glutamate (Glu) levels in healthy control subjects and in alcohol-dependent patients immediately after detoxification. The volumes of interest were located in the nucleus accumbens (NAcc) and the anterior cingulate cortex (ACC), which are two brain areas that have important functions in reward circuitry. In addition to Glu, we quantified the levels of combined Glu and glutamine (Gln), N-acetylaspartate, choline-containing compounds, and creatine. The Glu levels in the NAcc were significantly higher in patients than in controls. Craving, which was measured using the Obsessive Compulsive Drinking Scale, correlated positively with levels of combined Glu and Gln in the NAcc and in the ACC. The levels of all other metabolites were not significantly different between patients and controls. The increased Glu levels in the NAcc in alcohol-dependent patients shortly after detoxification confirm the animal data and suggest that striatal glutamatergic dysfunction is related to ethanol withdrawal. The positive correlation between craving and glutamatergic metabolism in both key reward circuitry areas support the hypothesis that the glutamatergic system has an important role in the later course of alcohol dependence with respect to abstinence and relapse.
The upregulation of glutamatergic excitatory neurotransmission is thought to be partly responsible for the acute withdrawal symptoms and craving experienced by alcohol-dependent patients. Most physiological evidence supporting this hypothesis is based on data from animal studies. In addition, clinical data show that GABAergic and anti-glutamatergic drugs ameliorate withdrawal symptoms, offering indirect evidence indicative of glutamatergic hyperexcitability in alcohol-dependent subjects. We used proton magnetic resonance spectroscopy to quantify the glutamate (Glu) levels in healthy control subjects and in alcohol-dependent patients immediately after detoxification. The volumes of interest were located in the nucleus accumbens (NAcc) and the anterior cingulate cortex (ACC), which are two brain areas that have important functions in reward circuitry. In addition to Glu, we quantified the levels of combined Glu and glutamine (Gln), N -acetylaspartate, choline-containing compounds, and creatine. The Glu levels in the NAcc were significantly higher in patients than in controls. Craving, which was measured using the Obsessive Compulsive Drinking Scale, correlated positively with levels of combined Glu and Gln in the NAcc and in the ACC. The levels of all other metabolites were not significantly different between patients and controls. The increased Glu levels in the NAcc in alcohol-dependent patients shortly after detoxification confirm the animal data and suggest that striatal glutamatergic dysfunction is related to ethanol withdrawal. The positive correlation between craving and glutamatergic metabolism in both key reward circuitry areas support the hypothesis that the glutamatergic system has an important role in the later course of alcohol dependence with respect to abstinence and relapse.
The upregulation of glutamatergic excitatory neurotransmission is thought to be partly responsible for the acute withdrawal symptoms and craving experienced by alcohol-dependent patients. Most physiological evidence supporting this hypothesis is based on data from animal studies. In addition, clinical data show that GABAergic and anti-glutamatergic drugs ameliorate withdrawal symptoms, offering indirect evidence indicative of glutamatergic hyperexcitability in alcohol-dependent subjects. We used proton magnetic resonance spectroscopy to quantify the glutamate (Glu) levels in healthy control subjects and in alcohol-dependent patients immediately after detoxification. The volumes of interest were located in the nucleus accumbens (NAcc) and the anterior cingulate cortex (ACC), which are two brain areas that have important functions in reward circuitry. In addition to Glu, we quantified the levels of combined Glu and glutamine (Gln), N-acetylaspartate, choline-containing compounds, and creatine. The Glu levels in the NAcc were significantly higher in patients than in controls. Craving, which was measured using the Obsessive Compulsive Drinking Scale, correlated positively with levels of combined Glu and Gln in the NAcc and in the ACC. The levels of all other metabolites were not significantly different between patients and controls. The increased Glu levels in the NAcc in alcohol-dependent patients shortly after detoxification confirm the animal data and suggest that striatal glutamatergic dysfunction is related to ethanol withdrawal. The positive correlation between craving and glutamatergic metabolism in both key reward circuitry areas support the hypothesis that the glutamatergic system has an important role in the later course of alcohol dependence with respect to abstinence and relapse.The upregulation of glutamatergic excitatory neurotransmission is thought to be partly responsible for the acute withdrawal symptoms and craving experienced by alcohol-dependent patients. Most physiological evidence supporting this hypothesis is based on data from animal studies. In addition, clinical data show that GABAergic and anti-glutamatergic drugs ameliorate withdrawal symptoms, offering indirect evidence indicative of glutamatergic hyperexcitability in alcohol-dependent subjects. We used proton magnetic resonance spectroscopy to quantify the glutamate (Glu) levels in healthy control subjects and in alcohol-dependent patients immediately after detoxification. The volumes of interest were located in the nucleus accumbens (NAcc) and the anterior cingulate cortex (ACC), which are two brain areas that have important functions in reward circuitry. In addition to Glu, we quantified the levels of combined Glu and glutamine (Gln), N-acetylaspartate, choline-containing compounds, and creatine. The Glu levels in the NAcc were significantly higher in patients than in controls. Craving, which was measured using the Obsessive Compulsive Drinking Scale, correlated positively with levels of combined Glu and Gln in the NAcc and in the ACC. The levels of all other metabolites were not significantly different between patients and controls. The increased Glu levels in the NAcc in alcohol-dependent patients shortly after detoxification confirm the animal data and suggest that striatal glutamatergic dysfunction is related to ethanol withdrawal. The positive correlation between craving and glutamatergic metabolism in both key reward circuitry areas support the hypothesis that the glutamatergic system has an important role in the later course of alcohol dependence with respect to abstinence and relapse.
Author Ohrmann, Patricia
Scherbaum, Norbert
Pedersen, Anya
Bauer, Jochen
Patschke, Johanna
Bening, Johanna
Kugel, Harald
Heindel, Walter
Arolt, Volker
Author_xml – sequence: 1
  givenname: Jochen
  surname: Bauer
  fullname: Bauer, Jochen
– sequence: 2
  givenname: Anya
  surname: Pedersen
  fullname: Pedersen, Anya
– sequence: 3
  givenname: Norbert
  surname: Scherbaum
  fullname: Scherbaum, Norbert
– sequence: 4
  givenname: Johanna
  surname: Bening
  fullname: Bening, Johanna
– sequence: 5
  givenname: Johanna
  surname: Patschke
  fullname: Patschke, Johanna
– sequence: 6
  givenname: Harald
  surname: Kugel
  fullname: Kugel, Harald
– sequence: 7
  givenname: Walter
  surname: Heindel
  fullname: Heindel, Walter
– sequence: 8
  givenname: Volker
  surname: Arolt
  fullname: Arolt, Volker
– sequence: 9
  givenname: Patricia
  surname: Ohrmann
  fullname: Ohrmann, Patricia
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=27477718$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/23403696$$D View this record in MEDLINE/PubMed
BookMark eNqNkl1rVDEQhoNU7IdeeS8BEQQ5a3KSk5PcCMuu1kJREYXehWxOspuSTbZJTml_jP_V7HbrR_HCqyF5n3kzk5ljcBBiMAA8x2iCEeFvw2YzaREmE9o9Ake4p6hhhF4cgCPEBWkwIReH4DjnS4Rw1zP-BBy2hCLCBDsCP2ZJXbuwhC7AqddxFX0zNxsTBhMK_KKKqzHDqS0mwbkp8cZZp-t1DPAsw6_Gq2IGWCI89WNR63pKS6fh_DbbMegdV63LysBPo_ZmrF5aj-uFCRmqMOyUaahZLiY4q5WMW0c4i6mYm6fgsVU-m2f7eAK-f3j_bfaxOf98ejabnje6I7w0qh9aojojesoNHRiyC9NaqwxBrPaprLXdQoiqd23f8YF0SnRYaczYwGnFTsC7O9_NuFibQdeek_Jyk9xapVsZlZN_K8Gt5DJeS8J4iymuBq_3BilejSYXuXZZG-9VMHHMEhMhBBYIsf9AWc85wryv6MsH6GUcU6g_saWYoIKS7dsv_iz-V9X3Q67Aqz2gslbeJhW0y7-5nvZ9j3nl8B2nU8w5GSu1K7tR156dlxjJ7cLJunByu3CSdjXnzYOce9t_0T8BninZsw
CODEN NEROEW
CitedBy_id crossref_primary_10_1097_JCP_0000000000000590
crossref_primary_10_1111_adb_70020
crossref_primary_10_1093_alcalc_agx119
crossref_primary_10_1038_s41380_022_01594_8
crossref_primary_10_1007_s13311_020_00851_4
crossref_primary_10_1111_acer_12977
crossref_primary_10_1111_acer_14879
crossref_primary_10_1111_adb_12810
crossref_primary_10_1111_adb_13107
crossref_primary_10_9758_cpn_2015_13_1_12
crossref_primary_10_3390_biomedicines9091161
crossref_primary_10_3389_fpsyt_2020_536706
crossref_primary_10_1186_s40810_015_0014_8
crossref_primary_10_1016_j_resp_2017_08_007
crossref_primary_10_1016_j_pbb_2021_173227
crossref_primary_10_1038_s41598_024_81390_2
crossref_primary_10_1111_acer_13931
crossref_primary_10_1523_JNEUROSCI_3383_16_2017
crossref_primary_10_1038_npp_2014_14
crossref_primary_10_1016_j_neulet_2015_11_017
crossref_primary_10_1111_acer_13131
crossref_primary_10_2967_jnumed_119_228825
crossref_primary_10_1172_JCI172884
crossref_primary_10_1080_13543784_2018_1501471
crossref_primary_10_2147_IJGM_S413193
crossref_primary_10_1016_j_drugalcdep_2014_12_028
crossref_primary_10_1111_jgs_12427
crossref_primary_10_1017_S1041610219001418
crossref_primary_10_1111_acer_14816
crossref_primary_10_1111_acer_12758
crossref_primary_10_3389_fneur_2021_641810
crossref_primary_10_1016_j_jns_2020_116763
crossref_primary_10_1111_adb_12238
crossref_primary_10_1111_adb_12635
crossref_primary_10_3390_ijms24054763
crossref_primary_10_1093_ijnp_pyx050
crossref_primary_10_1007_s00213_015_3868_3
crossref_primary_10_1016_j_neuroscience_2024_06_017
crossref_primary_10_1016_j_neuropharm_2023_109515
crossref_primary_10_1016_j_pscychresns_2020_111185
crossref_primary_10_1016_j_ynstr_2024_100657
crossref_primary_10_3390_brainsci11010062
crossref_primary_10_1007_s11432_019_2857_5
crossref_primary_10_1016_j_drugalcdep_2017_06_025
crossref_primary_10_1016_j_neubiorev_2015_11_010
crossref_primary_10_1002_brb3_2804
crossref_primary_10_1111_ner_12405
crossref_primary_10_3390_clinpract14010012
crossref_primary_10_1016_j_neubiorev_2013_06_011
crossref_primary_10_1002_brb3_769
crossref_primary_10_1016_j_nicl_2022_103091
crossref_primary_10_3389_fpsyt_2021_781668
crossref_primary_10_1007_s40473_013_0005_7
crossref_primary_10_1176_appi_ajp_2021_20121757
crossref_primary_10_3389_fpsyt_2018_00412
crossref_primary_10_1016_j_alcohol_2013_11_006
crossref_primary_10_5493_wjem_v15_i1_100402
crossref_primary_10_1016_j_neuroimage_2015_01_014
crossref_primary_10_3389_fnins_2014_00288
crossref_primary_10_2174_1381612826666200406090051
crossref_primary_10_1038_tp_2017_141
crossref_primary_10_1016_j_brainres_2015_01_002
crossref_primary_10_1038_s41537_022_00272_6
crossref_primary_10_1080_1354750X_2022_2049367
crossref_primary_10_1111_acer_12893
crossref_primary_10_1007_s00213_019_05228_w
crossref_primary_10_1111_adb_12291
crossref_primary_10_3389_fnins_2017_00686
crossref_primary_10_1002_jnr_24423
crossref_primary_10_51523_2708_6011_2014_11_2_1
crossref_primary_10_1124_pharmrev_121_000361
crossref_primary_10_3174_ajnr_A6632
crossref_primary_10_1016_j_alcohol_2022_08_004
crossref_primary_10_1007_s11432_019_2818_5
crossref_primary_10_1016_j_addicn_2021_100004
crossref_primary_10_1093_alcalc_agz062
crossref_primary_10_1038_s41598_023_29190_y
crossref_primary_10_1016_j_neulet_2021_136146
crossref_primary_10_1016_j_pnpbp_2024_111068
crossref_primary_10_1177_0269881119844178
crossref_primary_10_1227_NEU_0000000000001248
crossref_primary_10_12688_f1000research_9609_1
crossref_primary_10_3389_fncel_2016_00265
crossref_primary_10_1523_JNEUROSCI_1821_17_2017
crossref_primary_10_1016_j_neubiorev_2020_03_010
crossref_primary_10_1016_j_pneurobio_2018_10_001
crossref_primary_10_1016_j_neubiorev_2022_104821
crossref_primary_10_1016_j_addicn_2023_100137
crossref_primary_10_1093_alcalc_agad014
crossref_primary_10_3389_fpsyt_2019_00339
crossref_primary_10_1371_journal_pone_0136182
crossref_primary_10_1016_j_euroneuro_2019_09_002
crossref_primary_10_1016_j_alcohol_2021_01_004
crossref_primary_10_1097_JCP_0000000000000786
crossref_primary_10_3389_fphar_2015_00027
crossref_primary_10_1016_j_pscychresns_2021_111329
crossref_primary_10_1038_npp_2013_256
crossref_primary_10_1055_s_0041_1733866
crossref_primary_10_3389_fphar_2014_00158
Cites_doi 10.1097/WNR.0b013e3282ef7625
10.1038/mp.2011.46
10.1016/j.biopsych.2011.07.034
10.1016/j.pnpbp.2011.05.006
10.1111/j.1530-0277.2007.00344.x
10.1038/npp.2011.20
10.1016/j.biopsych.2009.09.016
10.1111/j.1360-0443.1993.tb02093.x
10.1002/mrm.1910300604
10.1016/S0306-4522(99)00250-X
10.1186/1747-597X-6-14
10.1093/alcalc/agr031
10.1016/S0014-2999(99)00209-5
10.1016/j.biopsych.2005.05.038
10.1002/nbm.1772
10.1177/0269881107078308
10.1002/jmri.22638
10.1093/alcalc/agh073
10.1002/mrm.21696
10.1002/jmri.21936
10.1001/archgenpsychiatry.2010.125
10.1001/archpsyc.1996.01830030047008
10.1002/nbm.2831
10.1016/j.addbeh.2004.06.020
10.1111/j.1530-0277.2011.01576.x
10.1037/0021-843X.110.1.40
10.1016/j.neuron.2004.09.016
10.1016/j.biopsych.2009.10.028
10.1152/physrev.00013.2008
10.1016/j.neuroscience.2007.02.016
10.1371/journal.pone.0036572
10.1097/01.ALC.0000167743.96121.40
10.1016/j.neuropharm.2012.02.022
10.1111/j.1749-6632.2009.05143.x
10.1055/s-2007-970144
10.1038/sj.npp.1301033
10.1111/j.1530-0277.1995.tb01475.x
10.1016/S0091-3057(99)00197-5
10.1016/j.ejrad.2009.11.003
10.3389/fnsys.2011.00094
10.1016/j.brainres.2006.11.046
10.1001/archgenpsychiatry.2010.93
10.1196/annals.1300.012
10.1016/j.bcp.2007.06.039
10.1111/j.1749-6632.1999.tb09260.x
10.1093/alcalc/agn100
10.1111/j.1369-1600.2009.00194.x
10.1097/01.ALC.0000150010.72739.58
ContentType Journal Article
Copyright 2015 INIST-CNRS
Copyright Nature Publishing Group Jul 2013
Copyright © 2013 American College of Neuropsychopharmacology 2013 American College of Neuropsychopharmacology
Copyright_xml – notice: 2015 INIST-CNRS
– notice: Copyright Nature Publishing Group Jul 2013
– notice: Copyright © 2013 American College of Neuropsychopharmacology 2013 American College of Neuropsychopharmacology
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7TK
7X7
7XB
88E
88G
8AO
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M2M
M7P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PSYQQ
Q9U
7X8
5PM
DOI 10.1038/npp.2013.45
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Neurosciences Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Psychology Database (Alumni)
ProQuest Pharma Collection
ProQuest SciTech Collection
ProQuest Natural Science Journals
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Medical Database
Psychology Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Psychology
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Psychology
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Psychology Journals (Alumni)
Biological Science Database
ProQuest SciTech Collection
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest Psychology Journals
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE
ProQuest One Psychology
Neurosciences Abstracts

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
Pharmacy, Therapeutics, & Pharmacology
DocumentTitleAlternate Glutamatergic dysfunction in alcoholics
EISSN 1740-634X
EndPage 1408
ExternalDocumentID PMC3682141
2994665261
23403696
27477718
10_1038_npp_2013_45
Genre Journal Article
GeographicLocations Germany
GeographicLocations_xml – name: Germany
GroupedDBID ---
-DZ
-Q-
0R~
29N
2WC
36B
39C
4.4
406
5RE
70F
7X7
88E
8AO
8FI
8FJ
8R4
8R5
AANZL
AASML
AAYXX
AAYZH
ABAKF
ABBRH
ABDBE
ABFSG
ABIVO
ABJNI
ABLJU
ABUWG
ABZZP
ACAOD
ACGFO
ACGFS
ACKTT
ACMFV
ACMJI
ACPRK
ACRQY
ACSTC
ACZOJ
ADBBV
ADFRT
AEFQL
AEJRE
AEMSY
AENEX
AESKC
AEVLU
AEXYK
AEZWR
AFBBN
AFDZB
AFHIU
AFKRA
AFRAH
AFSHS
AGAYW
AGHAI
AGQEE
AHMBA
AHSBF
AHWEU
AIGIU
AIXLP
AJRNO
ALFFA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMYLF
AOIJS
ASPBG
ATHPR
AVWKF
AYFIA
AZFZN
AZQEC
BAWUL
BBNVY
BENPR
BHPHI
BPHCQ
BVXVI
CCPQU
CITATION
CS3
DIK
DNIVK
DPUIP
DWQXO
E3Z
EBLON
EBS
EE.
EIOEI
EJD
EMB
EMOBN
F5P
FDB
FDQFY
FERAY
FIZPM
FSGXE
FYUFA
GNUQQ
GX1
HCIFZ
HMCUK
HYE
HZ~
IWAJR
JSO
JZLTJ
KQ8
M1P
M2M
M7P
MK0
NQJWS
O9-
OK1
P2P
P6G
PHGZM
PHGZT
PQQKQ
PROAC
PSQYO
PSYQQ
Q2X
RNT
RNTTT
ROL
RPM
SNX
SNYQT
SOHCF
SOJ
SRMVM
SV3
SWTZT
TAOOD
TBHMF
TDRGL
TR2
UKHRP
W2D
ZGI
--K
1B1
3V.
53G
5VS
AADWK
AAEDT
AALRI
AAPBV
AAQFI
AAQXK
AATNV
AAWBL
AAXUO
AAYFA
AAYJO
AAZLF
ABGIJ
ABMAC
ABPTK
ACBMV
ACBRV
ACBYP
ACIGE
ACIUM
ACTTH
ACVWB
ADHDB
ADMDM
ADMUD
ADQMX
ADYYL
AEDAW
AEFTE
AFNRJ
AGEZK
AGGBP
AILAN
AJCLW
AJDOV
AMRJV
CAG
COF
FEDTE
FGOYB
IHE
IQODW
M41
NAO
NQ-
NXXTH
NYICJ
R2-
RIG
RNS
RPZ
SEW
SSZ
ZKB
AACDK
ABWVN
ACRPL
ADNMO
CGR
CUY
CVF
ECM
EIF
FIGPU
HVGLF
LGEZI
LOTEE
NADUK
NPM
7TK
7XB
8FE
8FH
8FK
ABRTQ
K9.
LK8
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
Q9U
7X8
5PM
ID FETCH-LOGICAL-c538t-a7d23a5e9748e4d60fbe2ffae306036afff5b99e9752758d35a951ac166d84ae3
IEDL.DBID 7X7
ISSN 0893-133X
1740-634X
IngestDate Thu Aug 21 18:21:40 EDT 2025
Mon Jul 21 09:33:36 EDT 2025
Thu Jul 10 23:29:34 EDT 2025
Fri Jul 25 09:15:24 EDT 2025
Thu Apr 03 07:05:49 EDT 2025
Sun Oct 22 16:05:41 EDT 2023
Tue Jul 01 01:05:24 EDT 2025
Thu Apr 24 22:57:18 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords Human
Poison withdrawal
Alcoholism
Craving
Central nervous system
Detoxification
Basal ganglion
withdrawal
Glutamate
Encephalon
Nucleus accumbens
H MRS
Alcoholic beverage
Cingulate cortex
Dependence
Excitatory aminoacid
Neurotransmitter
Disintoxication
Language English
License http://www.springer.com/tdm
CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c538t-a7d23a5e9748e4d60fbe2ffae306036afff5b99e9752758d35a951ac166d84ae3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
These authors contributed equally to this work.
OpenAccessLink https://www.nature.com/articles/npp201345.pdf
PMID 23403696
PQID 1366949431
PQPubID 33935
PageCount 8
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3682141
proquest_miscellaneous_1399919006
proquest_miscellaneous_1367880187
proquest_journals_1366949431
pubmed_primary_23403696
pascalfrancis_primary_27477718
crossref_citationtrail_10_1038_npp_2013_45
crossref_primary_10_1038_npp_2013_45
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2013-07-01
PublicationDateYYYYMMDD 2013-07-01
PublicationDate_xml – month: 07
  year: 2013
  text: 2013-07-01
  day: 01
PublicationDecade 2010
PublicationPlace Basingstoke
PublicationPlace_xml – name: Basingstoke
– name: England
– name: New York
PublicationTitle Neuropsychopharmacology (New York, N.Y.)
PublicationTitleAlternate Neuropsychopharmacology
PublicationYear 2013
Publisher Nature Publishing Group
Publisher_xml – name: Nature Publishing Group
References K Moussawi (BFnpp201345_CR33) 2011; 5
R Spanagel (BFnpp201345_CR44) 2009; 89
D Hermann (BFnpp201345_CR19) 2012; 71
GA Miller (BFnpp201345_CR31) 2001; 110
P De Witte (BFnpp201345_CR7) 2004; 29
G Mason (BFnpp201345_CR30) 2005; 29
G Ende (BFnpp201345_CR9) 2005; 58
AE Kelley (BFnpp201345_CR23) 2004; 44
CB Fortier (BFnpp201345_CR10) 2011; 35
GM Khan (BFnpp201345_CR24) 1999; 373
G Mundle (BFnpp201345_CR35) 2006
RF Anton (BFnpp201345_CR3) 1995; 19
PW Kalivas (BFnpp201345_CR22) 2011; 16
PG Mullins (BFnpp201345_CR34) 2008; 60
EM Krupitsky (BFnpp201345_CR25) 2007; 31
F Wang (BFnpp201345_CR47) 2007; 32
JB Saunders (BFnpp201345_CR41) 1993; 88
N Omelchenko (BFnpp201345_CR36) 2007; 146
BFnpp201345_CR8
F Lallemand (BFnpp201345_CR26) 2011; 46
I Hancu (BFnpp201345_CR16) 2009; 30
M Heilig (BFnpp201345_CR17) 2010; 15
GR Siggins (BFnpp201345_CR43) 2003; 1003
RF Anton (BFnpp201345_CR2) 1996; 53
PE Alele (BFnpp201345_CR1) 2005; 29
M Hoerst (BFnpp201345_CR21) 2010; 67
J Gallinat (BFnpp201345_CR11) 2007; 40
Y Mashhoon (BFnpp201345_CR29) 2011; 35
S Modi (BFnpp201345_CR32) 2011; 79
A Dahchour (BFnpp201345_CR6) 2000; 65
SC Licata (BFnpp201345_CR28) 2010; 1187
B Gsellhofer (BFnpp201345_CR15) 1994
ZL Rossetti (BFnpp201345_CR40) 1999; 93
M Gu (BFnpp201345_CR14) 2012; 26
FC Zhou (BFnpp201345_CR51) 2007; 1134
J Besheer (BFnpp201345_CR4) 2010; 67
SW Provencher (BFnpp201345_CR37) 1993; 30
JC Umhau (BFnpp201345_CR46) 2010; 67
RJ Ward (BFnpp201345_CR48) 2009; 44
DL Rothman (BFnpp201345_CR39) 2011; 24
S Roesner (BFnpp201345_CR38) 2008; 22
AS Wijtenburg (BFnpp201345_CR49) 2011; 34
R Thoma (BFnpp201345_CR45) 2011; 36
P Schmidt (BFnpp201345_CR42) 2011; 6
M Heldmann (BFnpp201345_CR18) 2012; 7
NM Zahr (BFnpp201345_CR50) 2010; 67
DJ Hinton (BFnpp201345_CR20) 2012; 62
E Lee (BFnpp201345_CR27) 2007; 18
HJ Groenewegen (BFnpp201345_CR13) 1999; 877
M Bottlender (BFnpp201345_CR5) 2004; 39
JT Gass (BFnpp201345_CR12) 2008; 75
21919920 - Alcohol Clin Exp Res. 2011 Dec;35(12):2193-201
21761460 - J Magn Reson Imaging. 2011 Sep;34(3):645-52
22070867 - Addict Biol. 2013 Mar;18(2):379-91
21519339 - Mol Psychiatry. 2011 Oct;16(10):974-86
21711505 - Subst Abuse Treat Prev Policy. 2011;6:14
20148778 - Addict Biol. 2010 Apr;15(2):169-84
14684447 - Ann N Y Acad Sci. 2003 Nov;1003:196-211
15450168 - Neuron. 2004 Sep 30;44(1):161-79
19342616 - Physiol Rev. 2009 Apr;89(2):649-705
20603446 - Arch Gen Psychiatry. 2010 Sep;67(9):946-54
17198693 - Brain Res. 2007 Feb 23;1134(1):148-61
10415642 - Ann N Y Acad Sci. 1999 Jun 29;877:49-63
20201852 - Ann N Y Acad Sci. 2010 Feb;1187:148-71
19897175 - Biol Psychiatry. 2010 May 1;67(9):812-22
16452988 - Neuropsychopharmacology. 2007 Jan;32(1):103-9
7771669 - Alcohol Clin Exp Res. 1995 Feb;19(1):92-9
20921123 - Arch Gen Psychiatry. 2010 Oct;67(10):1069-77
17374039 - Alcohol Clin Exp Res. 2007 Apr;31(4):604-11
22275885 - Front Syst Neurosci. 2011 Nov 24;5:94
21389979 - Neuropsychopharmacology. 2011 Jun;36(7):1359-65
21478495 - Alcohol Alcohol. 2011 Jul-Aug;46(4):373-82
17712285 - Neuroreport. 2007 Sep 17;18(14):1511-4
17447175 - Pharmacopsychiatry. 2007 Mar;40(2):64-7
8611059 - Arch Gen Psychiatry. 1996 Mar;53(3):225-31
20022190 - Eur J Radiol. 2011 Jul;79(1):96-100
21616118 - Prog Neuropsychopharmacol Biol Psychiatry. 2011 Aug 15;35(7):1709-13
15976529 - Alcohol Clin Exp Res. 2005 Jun;29(6):1027-34
15345268 - Addict Behav. 2004 Sep;29(7):1325-39
17391856 - Neuroscience. 2007 May 25;146(3):1259-74
22616110 - Neuropharmacology. 2012 Jun;62(8):2480-8
8139448 - Magn Reson Med. 1993 Dec;30(6):672-9
19155229 - Alcohol Alcohol. 2009 Mar-Apr;44(2):128-35
11261398 - J Abnorm Psychol. 2001 Feb;110(1):40-8
15895489 - Alcohol Clin Exp Res. 2005 Jan;29(1):150-158
21907974 - Biol Psychiatry. 2012 Jun 1;71(11):1015-21
17706608 - Biochem Pharmacol. 2008 Jan 1;75(1):218-65
18816817 - Magn Reson Med. 2008 Oct;60(4):964-9
10414434 - Eur J Pharmacol. 1999 Jun 4;373(2-3):153-61
21882281 - NMR Biomed. 2011 Oct;24(8):943-57
22629317 - PLoS One. 2012;7(5):e36572
10672989 - Pharmacol Biochem Behav. 2000 Feb;65(2):345-50
18187529 - J Psychopharmacol. 2008 Jan;22(1):11-23
19856449 - J Magn Reson Imaging. 2009 Nov;30(5):1155-62
15208171 - Alcohol Alcohol. 2004 Jul-Aug;39(4):357-61
8329970 - Addiction. 1993 Jun;88(6):791-804
22761057 - NMR Biomed. 2013 Feb;26(2):164-72
20044076 - Biol Psychiatry. 2010 May 1;67(9):846-54
16084857 - Biol Psychiatry. 2005 Dec 15;58(12):974-80
10473277 - Neuroscience. 1999;93(3):1135-40
References_xml – ident: BFnpp201345_CR8
– volume: 18
  start-page: 1511
  year: 2007
  ident: BFnpp201345_CR27
  publication-title: Neuroreport
  doi: 10.1097/WNR.0b013e3282ef7625
– volume: 16
  start-page: 974
  year: 2011
  ident: BFnpp201345_CR22
  publication-title: Mol Psychiatry
  doi: 10.1038/mp.2011.46
– volume: 71
  start-page: 1015
  year: 2012
  ident: BFnpp201345_CR19
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2011.07.034
– volume: 35
  start-page: 1709
  year: 2011
  ident: BFnpp201345_CR29
  publication-title: Neuropsychopharmacol Biol Psychiatry
  doi: 10.1016/j.pnpbp.2011.05.006
– volume: 31
  start-page: 604
  year: 2007
  ident: BFnpp201345_CR25
  publication-title: Alcohol Clin Exp Res
  doi: 10.1111/j.1530-0277.2007.00344.x
– volume: 36
  start-page: 1359
  year: 2011
  ident: BFnpp201345_CR45
  publication-title: Neuropsycho-pharmacology
  doi: 10.1038/npp.2011.20
– volume: 67
  start-page: 812
  year: 2010
  ident: BFnpp201345_CR4
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2009.09.016
– volume: 88
  start-page: 791
  year: 1993
  ident: BFnpp201345_CR41
  publication-title: Addiction
  doi: 10.1111/j.1360-0443.1993.tb02093.x
– volume: 30
  start-page: 672
  year: 1993
  ident: BFnpp201345_CR37
  publication-title: Magn. Reson. Med
  doi: 10.1002/mrm.1910300604
– volume: 93
  start-page: 1135
  year: 1999
  ident: BFnpp201345_CR40
  publication-title: Neuroscience
  doi: 10.1016/S0306-4522(99)00250-X
– volume: 6
  start-page: 14
  year: 2011
  ident: BFnpp201345_CR42
  publication-title: Subst Abuse Treat Prev Policy
  doi: 10.1186/1747-597X-6-14
– volume: 46
  start-page: 373
  year: 2011
  ident: BFnpp201345_CR26
  publication-title: Alcohol Alcohol
  doi: 10.1093/alcalc/agr031
– volume: 373
  start-page: 153
  year: 1999
  ident: BFnpp201345_CR24
  publication-title: Eur J Pharmacol
  doi: 10.1016/S0014-2999(99)00209-5
– volume: 58
  start-page: 974
  year: 2005
  ident: BFnpp201345_CR9
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2005.05.038
– volume: 24
  start-page: 943
  year: 2011
  ident: BFnpp201345_CR39
  publication-title: NMR Biomed
  doi: 10.1002/nbm.1772
– volume: 22
  start-page: 11
  year: 2008
  ident: BFnpp201345_CR38
  publication-title: J Psychopharmacol
  doi: 10.1177/0269881107078308
– volume: 34
  start-page: 645
  year: 2011
  ident: BFnpp201345_CR49
  publication-title: J Magnetic Resonance Imaging
  doi: 10.1002/jmri.22638
– volume: 39
  start-page: 357
  year: 2004
  ident: BFnpp201345_CR5
  publication-title: Alcohol Alcohol
  doi: 10.1093/alcalc/agh073
– volume: 60
  start-page: 964
  year: 2008
  ident: BFnpp201345_CR34
  publication-title: Magn Res Med
  doi: 10.1002/mrm.21696
– volume: 30
  start-page: 1155
  year: 2009
  ident: BFnpp201345_CR16
  publication-title: J Magn Reson Imaging
  doi: 10.1002/jmri.21936
– volume-title: Manual für Training und Durchführung von Interviews mit dem EuropASI
  year: 1994
  ident: BFnpp201345_CR15
– volume: 67
  start-page: 1069
  year: 2010
  ident: BFnpp201345_CR46
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archgenpsychiatry.2010.125
– volume: 53
  start-page: 225
  year: 1996
  ident: BFnpp201345_CR2
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archpsyc.1996.01830030047008
– volume: 26
  start-page: 164
  year: 2012
  ident: BFnpp201345_CR14
  publication-title: NMR Biomed
  doi: 10.1002/nbm.2831
– volume: 29
  start-page: 1325
  year: 2004
  ident: BFnpp201345_CR7
  publication-title: Addict Behav
  doi: 10.1016/j.addbeh.2004.06.020
– volume: 35
  start-page: 2193
  year: 2011
  ident: BFnpp201345_CR10
  publication-title: Alcohol Clin Exp Res
  doi: 10.1111/j.1530-0277.2011.01576.x
– volume: 110
  start-page: 40
  year: 2001
  ident: BFnpp201345_CR31
  publication-title: J Abnorm Psychol
  doi: 10.1037/0021-843X.110.1.40
– volume: 44
  start-page: 161
  year: 2004
  ident: BFnpp201345_CR23
  publication-title: Neuron
  doi: 10.1016/j.neuron.2004.09.016
– volume: 67
  start-page: 846
  year: 2010
  ident: BFnpp201345_CR50
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2009.10.028
– volume: 89
  start-page: 649
  year: 2009
  ident: BFnpp201345_CR44
  publication-title: Physiol Rev
  doi: 10.1152/physrev.00013.2008
– volume: 146
  start-page: 1259
  year: 2007
  ident: BFnpp201345_CR36
  publication-title: Neuroscience
  doi: 10.1016/j.neuroscience.2007.02.016
– volume: 7
  start-page: e36572
  year: 2012
  ident: BFnpp201345_CR18
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0036572
– volume: 29
  start-page: 1027
  year: 2005
  ident: BFnpp201345_CR1
  publication-title: Alcohol Clin Exp Res
  doi: 10.1097/01.ALC.0000167743.96121.40
– volume: 62
  start-page: 2480
  year: 2012
  ident: BFnpp201345_CR20
  publication-title: Neuropharmacology
  doi: 10.1016/j.neuropharm.2012.02.022
– volume: 1187
  start-page: 148
  year: 2010
  ident: BFnpp201345_CR28
  publication-title: Ann N Y Acad Sci
  doi: 10.1111/j.1749-6632.2009.05143.x
– volume: 40
  start-page: 64
  year: 2007
  ident: BFnpp201345_CR11
  publication-title: Pharmacopsychiatry
  doi: 10.1055/s-2007-970144
– volume: 32
  start-page: 103
  year: 2007
  ident: BFnpp201345_CR47
  publication-title: Neuropsychopharmacology
  doi: 10.1038/sj.npp.1301033
– volume: 19
  start-page: 92
  year: 1995
  ident: BFnpp201345_CR3
  publication-title: Alcohol Clin Exp Res
  doi: 10.1111/j.1530-0277.1995.tb01475.x
– volume: 65
  start-page: 345
  year: 2000
  ident: BFnpp201345_CR6
  publication-title: Pharmacol Biochem Behav
  doi: 10.1016/S0091-3057(99)00197-5
– volume: 79
  start-page: 96
  year: 2011
  ident: BFnpp201345_CR32
  publication-title: Eur J Radiol
  doi: 10.1016/j.ejrad.2009.11.003
– volume: 5
  start-page: 94
  year: 2011
  ident: BFnpp201345_CR33
  publication-title: Front Syst Neurosci
  doi: 10.3389/fnsys.2011.00094
– volume: 1134
  start-page: 148
  year: 2007
  ident: BFnpp201345_CR51
  publication-title: Brain Res
  doi: 10.1016/j.brainres.2006.11.046
– volume: 67
  start-page: 946
  year: 2010
  ident: BFnpp201345_CR21
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archgenpsychiatry.2010.93
– volume: 1003
  start-page: 196
  year: 2003
  ident: BFnpp201345_CR43
  publication-title: Ann N Y Acad Sci
  doi: 10.1196/annals.1300.012
– start-page: 25
  volume-title: Evidenzbasierte Suchtmedizin
  year: 2006
  ident: BFnpp201345_CR35
– volume: 75
  start-page: 218
  year: 2008
  ident: BFnpp201345_CR12
  publication-title: Biochem Pharmacol
  doi: 10.1016/j.bcp.2007.06.039
– volume: 877
  start-page: 49
  year: 1999
  ident: BFnpp201345_CR13
  publication-title: Ann N Y Acad Sci
  doi: 10.1111/j.1749-6632.1999.tb09260.x
– volume: 44
  start-page: 128
  year: 2009
  ident: BFnpp201345_CR48
  publication-title: Alcohol Alcohol
  doi: 10.1093/alcalc/agn100
– volume: 15
  start-page: 169
  year: 2010
  ident: BFnpp201345_CR17
  publication-title: Addict Biol
  doi: 10.1111/j.1369-1600.2009.00194.x
– volume: 29
  start-page: 150
  year: 2005
  ident: BFnpp201345_CR30
  publication-title: Alcohol Clin Exp Res
  doi: 10.1097/01.ALC.0000150010.72739.58
– reference: 15345268 - Addict Behav. 2004 Sep;29(7):1325-39
– reference: 15450168 - Neuron. 2004 Sep 30;44(1):161-79
– reference: 21711505 - Subst Abuse Treat Prev Policy. 2011;6:14
– reference: 8139448 - Magn Reson Med. 1993 Dec;30(6):672-9
– reference: 18816817 - Magn Reson Med. 2008 Oct;60(4):964-9
– reference: 21907974 - Biol Psychiatry. 2012 Jun 1;71(11):1015-21
– reference: 14684447 - Ann N Y Acad Sci. 2003 Nov;1003:196-211
– reference: 19856449 - J Magn Reson Imaging. 2009 Nov;30(5):1155-62
– reference: 20201852 - Ann N Y Acad Sci. 2010 Feb;1187:148-71
– reference: 17706608 - Biochem Pharmacol. 2008 Jan 1;75(1):218-65
– reference: 21882281 - NMR Biomed. 2011 Oct;24(8):943-57
– reference: 19342616 - Physiol Rev. 2009 Apr;89(2):649-705
– reference: 20148778 - Addict Biol. 2010 Apr;15(2):169-84
– reference: 17198693 - Brain Res. 2007 Feb 23;1134(1):148-61
– reference: 19155229 - Alcohol Alcohol. 2009 Mar-Apr;44(2):128-35
– reference: 10672989 - Pharmacol Biochem Behav. 2000 Feb;65(2):345-50
– reference: 19897175 - Biol Psychiatry. 2010 May 1;67(9):812-22
– reference: 7771669 - Alcohol Clin Exp Res. 1995 Feb;19(1):92-9
– reference: 22616110 - Neuropharmacology. 2012 Jun;62(8):2480-8
– reference: 10473277 - Neuroscience. 1999;93(3):1135-40
– reference: 15208171 - Alcohol Alcohol. 2004 Jul-Aug;39(4):357-61
– reference: 20044076 - Biol Psychiatry. 2010 May 1;67(9):846-54
– reference: 18187529 - J Psychopharmacol. 2008 Jan;22(1):11-23
– reference: 22070867 - Addict Biol. 2013 Mar;18(2):379-91
– reference: 10414434 - Eur J Pharmacol. 1999 Jun 4;373(2-3):153-61
– reference: 16452988 - Neuropsychopharmacology. 2007 Jan;32(1):103-9
– reference: 21519339 - Mol Psychiatry. 2011 Oct;16(10):974-86
– reference: 17391856 - Neuroscience. 2007 May 25;146(3):1259-74
– reference: 21919920 - Alcohol Clin Exp Res. 2011 Dec;35(12):2193-201
– reference: 17712285 - Neuroreport. 2007 Sep 17;18(14):1511-4
– reference: 10415642 - Ann N Y Acad Sci. 1999 Jun 29;877:49-63
– reference: 22761057 - NMR Biomed. 2013 Feb;26(2):164-72
– reference: 20921123 - Arch Gen Psychiatry. 2010 Oct;67(10):1069-77
– reference: 8611059 - Arch Gen Psychiatry. 1996 Mar;53(3):225-31
– reference: 15976529 - Alcohol Clin Exp Res. 2005 Jun;29(6):1027-34
– reference: 11261398 - J Abnorm Psychol. 2001 Feb;110(1):40-8
– reference: 22275885 - Front Syst Neurosci. 2011 Nov 24;5:94
– reference: 17447175 - Pharmacopsychiatry. 2007 Mar;40(2):64-7
– reference: 20603446 - Arch Gen Psychiatry. 2010 Sep;67(9):946-54
– reference: 21616118 - Prog Neuropsychopharmacol Biol Psychiatry. 2011 Aug 15;35(7):1709-13
– reference: 21389979 - Neuropsychopharmacology. 2011 Jun;36(7):1359-65
– reference: 20022190 - Eur J Radiol. 2011 Jul;79(1):96-100
– reference: 16084857 - Biol Psychiatry. 2005 Dec 15;58(12):974-80
– reference: 22629317 - PLoS One. 2012;7(5):e36572
– reference: 8329970 - Addiction. 1993 Jun;88(6):791-804
– reference: 17374039 - Alcohol Clin Exp Res. 2007 Apr;31(4):604-11
– reference: 21478495 - Alcohol Alcohol. 2011 Jul-Aug;46(4):373-82
– reference: 15895489 - Alcohol Clin Exp Res. 2005 Jan;29(1):150-158
– reference: 21761460 - J Magn Reson Imaging. 2011 Sep;34(3):645-52
SSID ssj0015768
Score 2.4222884
Snippet The upregulation of glutamatergic excitatory neurotransmission is thought to be partly responsible for the acute withdrawal symptoms and craving experienced by...
SourceID pubmedcentral
proquest
pubmed
pascalfrancis
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1401
SubjectTerms Abstinence
Addictive behaviors
Adult
Adult and adolescent clinical studies
Alcoholism
Alcoholism - diagnosis
Alcoholism - metabolism
Alcoholism - therapy
Alcoholism and acute alcohol poisoning
Behavior, Addictive - diagnosis
Behavior, Addictive - metabolism
Behavior, Addictive - therapy
Biological and medical sciences
Brain
Desintoxication. Drug withdrawal
Drug withdrawal
Ethanol
Female
Glutamic Acid - metabolism
Gyrus Cinguli - metabolism
Humans
Hypotheses
Magnetic Resonance Spectroscopy - methods
Male
Medical sciences
Metabolism
Metabolites
Middle Aged
Nucleus Accumbens - metabolism
Original
Physiology
Psychiatry
Psychology. Psychoanalysis. Psychiatry
Psychopathology. Psychiatry
Spectrum analysis
Substance Withdrawal Syndrome - diagnosis
Substance Withdrawal Syndrome - metabolism
Substance Withdrawal Syndrome - therapy
Surveys and Questionnaires
Toxicology
Treatments
Title Craving in Alcohol-Dependent Patients After Detoxification Is Related to Glutamatergic Dysfunction in the Nucleus Accumbens and the Anterior Cingulate Cortex
URI https://www.ncbi.nlm.nih.gov/pubmed/23403696
https://www.proquest.com/docview/1366949431
https://www.proquest.com/docview/1367880187
https://www.proquest.com/docview/1399919006
https://pubmed.ncbi.nlm.nih.gov/PMC3682141
Volume 38
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fa9RAEB60BRGK6FVttB4rSB-ksUk2PzZPEu9aq9DjkBbuLWySDR7o5rzkoPfH-L86s8nlelL6vJOwZCYz38zOzgfwIXdEFmU8tH2vkLavlGtnkcgx50F0mgniXKU65NUkvLzxv8-CWVdwq7u2yo1PNI66qHKqkZ-5PAxjP8Z493nxxybWKDpd7Sg0HsM-jS4jq45mfcLlEpY2KDLmNuZis-5-nsPFmV7QsEqXf6J7THci0sFC1vhxypbV4j7Y-X_35J1wdPEcnnU4kiWt4l_AI6UHcJhozKF_r9kJM52dpmQ-gCdX3QH6AE6m7ajq9Sm73t68qk_NE_0Q6_Uh_B0tJdUa2FyzpKXRtccdYW7Dpu001polRDHOxqqpbqnnyKiZfauZ6bFTBWsq9hVtWyIuVkt0smy8rimUGjl8NcJPNqGRyit8V54TPYmumdSFWUlI6_NqyUa4E-IZU2xEzcG3L-Hm4vx6dGl3VA52jh61sWVUeFwGCrMXofwidMpMeWUpFWYsGENlWZZBFse4HniYwRQ8kAj9ZO6GYSF8FHsFe7rS6ggY5muhQCAqJRmSg3CliDM6es5jT3FPWPBxo8407-acE93Gr9Sct3ORou5T0n3qBxZa60Z40Y73uF9suGMXvSzl9BGGdwuON4aSdk6gTrcma8H7fhl_XzqTkVpVKyMToQt1RfSQDKH4GP2jBa9b29tugPsOUTJaEO1YZS9A48N3V_T8pxkjzkPhub775uGtv4WnnmEAoQ7lY9hrliv1DnFYkw3NzzaE_S_nk-mPf0fHNy4
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VIgESQpDyMJSySNADqqnt9WN9QChKKAltoh5aKTd3ba9FJLBD7Ijmx_AX-I3MrO2kQVVvPe_YWmke-83s7HwA7xJLxEHMfdN1Umm6StlmHIgEcx5Ep7EgzlWqQ47G_uDc_TbxJlvwt30LQ22VbUzUgTotEqqRH9rc90M3xPPu8-yXSaxRdLvaUmjUZnGslr8xZSs_Dfuo3_eOc_TlrDcwG1YBM0HnrkwZpA6XnkIgLZSb-lYWKyfLpELwjOFcZlnmxWGI656DYDrlnkQUIhPb91Phohj-9w7cxY1YlOwFk1WCZxN216g15CbmfpPmPaDFxWE-o-GYNv9I76aunIAPZ7JEZWQ1i8Z1MPf_bs0rx9_RY3jU4FbWrQ3tCWypvAM73Rxz9p9Lts90J6ku0Xfg3qi5sO_A_mk9Gnt5wM7WL73KA_3Famj2cgf-9OaSahtsmrNuTdtr9huC3oqd1tNfS9YlSnPWV1VxST1O2qzYsGS6p0-lrCrYV_QliThczTGos_6ypKNby-GvEe6yMY1wXuC_koToUPKSyTzVK12ysmkxZz3cCfGaKdajZuTLp3B-K0p-Btt5kasXwDA_9AUCXynJcC2ER2kY01V3EjqKO8KAD606o6SZq070Hj8ifb_PRYS6j0j3kesZ6B2t8KweJ3K92N6GXaxkqYYQIJwwYLc1lKgJOmW0dhED3q6WMVzQHZDMVbHQMgGGbFsEN8lQ1hBiPDbgeW176w1w1yIKSAOCDatcCdC48s2VfPpdjy3nvnBs135589bfwP3B2egkOhmOj1_BA0ezj1B39C5sV_OFeo0YsIr3tOMxuLhtT_8HvA5zKw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3bbtNAEB2VVKqQEIKWi6GURYI-oJrEXl_WDwiFpKGhNIpQK-XNrO21iAR2iB3RfAw_wtcxs7aTBlV96_OOV5bmsmd2ZucAvI47IvIj7pmOnUjTUcoyI1_EmPMgOo0Eca7SPeTZyDu5cD5P3MkW_G3ewlBbZRMTdaBO8pjuyNsW97zACfC8a6d1W8S4P_gw-2USgxRVWhs6jcpETtXyN6ZvxfthH3X9xrYHx-e9E7NmGDBjdPTSlH5ic-kqBNVCOYnXSSNlp6lUCKQxtMs0Td0oCHDdtRFYJ9yViEhkbHleIhwUw33vwLZPWVELtj8ej8ZfVzUMQvIawwbcxExwUr8O7HDRzmY0KtPi7-gV1ZXz8N5MFqiatOLUuA70_t-7eeUwHDyA-zWKZd3K7B7Clsp2Ya-bYQb_c8kOme4r1Rf2u7BzVpfvd-FwXA3KXh6x8_W7r-JIf7Eaob3cgz-9uaSbDjbNWLci8TX7NV1vycbVLNiCdYngnPVVmV9Sx5M2MjYsmO7wUwkrc_YJPUsiKldzDPGsvyzoINdyuDWCXzaigc4L3CuOiRwlK5jMEr3SJZub5nPWwz8hljPFetSafPkILm5FzY-hleWZegoMs0VPIAyWksy4g2ApCSIqfMeBrbgtDHjbqDOM6ynrRPbxI9TVfi5C1H1Iug8d10BfaYRn1XCR68UONuxiJUs3Cj6CCwP2G0MJ6xBUhGuHMeDVahmDB1WEZKbyhZbxMYBbwr9JhnKIAKOzAU8q21v_AHc6RAhpgL9hlSsBGl6-uZJNv-sh5twTtuVYz27-9Zewg14efhmOTp_DXVtTkVCr9D60yvlCvUBAWEYHtecx-Hbbzv4PHKN4xg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Craving+in+alcohol-dependent+patients+after+detoxification+is+related+to+glutamatergic+dysfunction+in+the+nucleus+accumbens+and+the+anterior+cingulate+cortex&rft.jtitle=Neuropsychopharmacology+%28New+York%2C+N.Y.%29&rft.au=Bauer%2C+Jochen&rft.au=Pedersen%2C+Anya&rft.au=Scherbaum%2C+Norbert&rft.au=Bening%2C+Johanna&rft.date=2013-07-01&rft.issn=1740-634X&rft.eissn=1740-634X&rft.volume=38&rft.issue=8&rft.spage=1401&rft_id=info:doi/10.1038%2Fnpp.2013.45&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0893-133X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0893-133X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0893-133X&client=summon